Journal chief editors cite “unavailability of original data and records and ambiguous identification of samples and treatments,” as to why the publication retracted six papers by a nutritional researcher – his 12th in total.
The supplement industry has an opportunity to make a powerful case about its self regulatory capabilities during the interregnum of federal regulatory authority imposed by the budget impasse.
The multi-level marketing giant Herbalife announced that CEO Richard Goudis resigned due to comments on “expense-related policies and business practices,” the company said in a press release.
By George Paraskevakos, Executive Director, International Probiotics Association (IPA)
As I celebrated three years at IPA in April, I couldn’t help but reflect on the shape the industry has taken. Going from being sparingly mentioned in the press and fast forward to today and it is almost every other week we see probiotics in the headlines....
By Steve Mister, president/CEO of the Council for Responsible Nutrition (CRN)
Unless you’ve been living in a tree, most stakeholders in the dietary supplement industry have heard of the Supplement OWL. Please pardon the pun, but “hoo” hasn’t?
By Ellen Schutt, Executive Director, GOED (Global Organization for EPA & DHA Omega-3)
New science, developments in contaminant regulations, a new conversation around micro- and nanoplastics, and challenges on the regulatory front: In this guest article, Ellen Schutt, Executive Director of GOED, looks back on a very busy 2018 in the omega-3...
Most dietary supplement consumers expect a product to have scientific backing, so putting science at the forefront of a marketing or branding campaign just comes off as ‘noise,’ said one branding expert.
Two new large-scale and well-conducted clinical trials found that a short course of Lactobacillus rhamnosus GG or L. rhamnosus R0011 plus L. helveticus R0052 did not improve gastroenteritis symptoms in children.
From the 2018 midterm election results to the rise of CBD, Michael McGuffin, president of the American Herbal Products Association, talks about how the association is approaching the most recent changes in the supplements space.
Four trade associations have sent out warnings to the public regarding ‘phenibut,’ which they say is a dangerous substance illegally posing as a dietary supplement.
The Nagoya Protocol, the big changes coming for Lactobacillus classification, and how to boost your chances of success with an NDI notification were just some of the topic covered during the third annual IPA Workshop in DC.
As the Supplement OWL approaches 12,000 labels in its Tier 1 product label library, the Council for Responsible has announced a new pilot program to build out Tier 2, which will be known as the Commercial Data Exchange, or CDX.
A paper that published this morning in the JAMA Network Open journal found that FDA had identified 776 adulterated dietary supplements in a 10-year period ending in 2016. As most of these products were tainted with drugs, calling them ‘supplements’ was...
Does DHSEA contain within it the seeds of the industry’s downfall? The freewheeling marketplace this regulation created has placed the barriers to entry so low that less than reputable companies have room to maneuver, creating risk for the whole industry.
